These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38382050)

  • 1. Protein-Engineered Hirudins with Enhanced Anticoagulant Activities Developed by a Molecular Integrative Approach.
    Sun Y; Wang D
    J Med Chem; 2024 Mar; 67(5):3203-3204. PubMed ID: 38382050
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the anticoagulant activities of thrombin inhibitors as assessed by thromboelastographic analysis.
    Callas D; Iqbal O; Fareed J
    Semin Thromb Hemost; 1995; 21 Suppl 4():76-9. PubMed ID: 8747693
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular dynamic and pharmacological studies on protein-engineered hirudin variants of Hirudinaria manillensis and Hirudo medicinalis.
    Sun Y; Wang B; Pei J; Luo Y; Yuan N; Xiao Z; Wu H; Luo C; Wang J; Wei S; Pei Y; Fu S; Wang D
    Br J Pharmacol; 2022 Jul; 179(14):3740-3753. PubMed ID: 35135035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anticoagulant and antithrombotic properties of hirudins.
    Märki WE; Wallis RB
    Thromb Haemost; 1990 Nov; 64(3):344-8. PubMed ID: 2096484
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative comparison of recombinant hirudin's antithrombotic and anticoagulant activities with those of heparin.
    Porta R; Pescador R; Mantovani M; Prino G
    Thromb Res; 1990 Feb; 57(4):639-43. PubMed ID: 2326777
    [No Abstract]   [Full Text] [Related]  

  • 6. Hirudin and derivatives as anticoagulant agents.
    Markwardt F
    Thromb Haemost; 1991 Jul; 66(1):141-52. PubMed ID: 1926044
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficient targeted anticoagulant with active RGD motif.
    Bi Q; Zhou X; Cen X; Qu H; Luo J; Huang Y; Zhu S
    Thromb Res; 2007; 120(4):541-7. PubMed ID: 17222892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hirudin: the famous anticoagulant agent.
    Markwardt F
    Adv Exp Med Biol; 1993; 340():191-211. PubMed ID: 8154337
    [No Abstract]   [Full Text] [Related]  

  • 9. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant and antithrombotic action of the factor Xa inhibitor antistasin (ATS).
    Hauptmann J; Kaiser B
    Thromb Res; 1993 Jul; 71(2):169-74. PubMed ID: 8362380
    [No Abstract]   [Full Text] [Related]  

  • 11. Hirudins: from leeches to man.
    Wallis RB
    Semin Thromb Hemost; 1996; 22(2):185-96. PubMed ID: 8807716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-regulated hirudin delivery for anticoagulant therapy.
    Xu X; Huang X; Zhang Y; Shen S; Feng Z; Dong H; Zhang C; Mo R
    Sci Adv; 2020 Oct; 6(41):. PubMed ID: 33036973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life without blood: Molecular and functional analysis of hirudins and hirudin-like factors of the Asian non-hematophagous leech Whitmania pigra.
    Müller C; Wang Z; Hamann M; Sponholz D; Hildebrandt JP
    J Thromb Haemost; 2022 Aug; 20(8):1808-1817. PubMed ID: 35587545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hirudins: antithrombin anticoagulants.
    Stringer KA; Lindenfeld J
    Ann Pharmacother; 1992 Dec; 26(12):1535-40. PubMed ID: 1482812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current challenges of anticoagulant treatment.
    Ginghină C; Giuşcă S; Serban M; Popescu BA; Jurcuţ R; Uscăţescu V
    Rom J Intern Med; 2007; 45(3):221-7. PubMed ID: 18333353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal models.
    Bacher P; Walenga JM; Iqbal O; Bajusz S; Breddin K; Fareed J
    Thromb Res; 1993 Aug; 71(4):251-63. PubMed ID: 8236155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USAN Council. List No. 374. New names. Bivalirudin. Desirudin.
    Clin Pharmacol Ther; 1995 Aug; 58(2):241. PubMed ID: 7648776
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin.
    Callas DD; Hoppensteadt D; Fareed J
    Semin Thromb Hemost; 1995; 21(2):177-83. PubMed ID: 7660140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal Anticoagulation With Bivalirudin; Is the Best Still to Come?
    Lahart M; Said AS
    ASAIO J; 2022 Nov; 68(11):e223. PubMed ID: 36326707
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticoagulant potential of synthetic and recombinant inhibitors of factor Xa and thrombin in vitro.
    Hauptmann J; Kaiser B
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):577-82. PubMed ID: 8218854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.